185 related articles for article (PubMed ID: 11885026)
1. Heparin inhibition of selectin-mediated interactions during the hematogenous phase of carcinoma metastasis: rationale for clinical studies in humans.
Varki NM; Varki A
Semin Thromb Hemost; 2002 Feb; 28(1):53-66. PubMed ID: 11885026
[TBL] [Abstract][Full Text] [Related]
2. P-selectin, carcinoma metastasis and heparin: novel mechanistic connections with therapeutic implications.
Varki A; Varki NM
Braz J Med Biol Res; 2001 Jun; 34(6):711-7. PubMed ID: 11378658
[TBL] [Abstract][Full Text] [Related]
3. Antimetastatic activities of modified heparins: selectin inhibition by heparin attenuates metastasis.
Borsig L
Semin Thromb Hemost; 2007 Jul; 33(5):540-6. PubMed ID: 17629852
[TBL] [Abstract][Full Text] [Related]
4. Heparin and cancer revisited: mechanistic connections involving platelets, P-selectin, carcinoma mucins, and tumor metastasis.
Borsig L; Wong R; Feramisco J; Nadeau DR; Varki NM; Varki A
Proc Natl Acad Sci U S A; 2001 Mar; 98(6):3352-7. PubMed ID: 11248082
[TBL] [Abstract][Full Text] [Related]
5. Melanoma cell adhesion can be blocked by heparin in vitro: suggestion of VLA-4 as a novel target for antimetastatic approaches.
Fritzsche J; Simonis D; Bendas G
Thromb Haemost; 2008 Dec; 100(6):1166-75. PubMed ID: 19132244
[TBL] [Abstract][Full Text] [Related]
6. Heparin attenuates metastasis mainly due to inhibition of P- and L-selectin, but non-anticoagulant heparins can have additional effects.
Stevenson JL; Varki A; Borsig L
Thromb Res; 2007; 120 Suppl 2():S107-11. PubMed ID: 18023703
[TBL] [Abstract][Full Text] [Related]
7. P-selectin mediates metastatic progression through binding to sulfatides on tumor cells.
Garcia J; Callewaert N; Borsig L
Glycobiology; 2007 Feb; 17(2):185-96. PubMed ID: 17043066
[TBL] [Abstract][Full Text] [Related]
8. Selectins promote tumor metastasis.
Läubli H; Borsig L
Semin Cancer Biol; 2010 Jun; 20(3):169-77. PubMed ID: 20452433
[TBL] [Abstract][Full Text] [Related]
9. P-selectin- and heparanase-dependent antimetastatic activity of non-anticoagulant heparins.
Hostettler N; Naggi A; Torri G; Ishai-Michaeli R; Casu B; Vlodavsky I; Borsig L
FASEB J; 2007 Nov; 21(13):3562-72. PubMed ID: 17557930
[TBL] [Abstract][Full Text] [Related]
10. L-selectin facilitation of metastasis involves temporal induction of Fut7-dependent ligands at sites of tumor cell arrest.
Läubli H; Stevenson JL; Varki A; Varki NM; Borsig L
Cancer Res; 2006 Feb; 66(3):1536-42. PubMed ID: 16452210
[TBL] [Abstract][Full Text] [Related]
11. Heparins attenuate cancer metastasis: are selectins the link?
Laubli H; Borsig L
Cancer Invest; 2009 Jun; 27(5):474-81. PubMed ID: 19479484
[TBL] [Abstract][Full Text] [Related]
12. Mechanisms of heparin induced anti-cancer activity in experimental cancer models.
Niers TM; Klerk CP; DiNisio M; Van Noorden CJ; Büller HR; Reitsma PH; Richel DJ
Crit Rev Oncol Hematol; 2007 Mar; 61(3):195-207. PubMed ID: 17074500
[TBL] [Abstract][Full Text] [Related]
13. Antimetastatic effect of an orally active heparin derivative on experimentally induced metastasis.
Lee DY; Park K; Kim SK; Park RW; Kwon IC; Kim SY; Byun Y
Clin Cancer Res; 2008 May; 14(9):2841-9. PubMed ID: 18451252
[TBL] [Abstract][Full Text] [Related]
14. Selectively desulfated heparin inhibits P-selectin-mediated adhesion of human melanoma cells.
Wei M; Gao Y; Tian M; Li N; Hao S; Zeng X
Cancer Lett; 2005 Nov; 229(1):123-6. PubMed ID: 16157224
[TBL] [Abstract][Full Text] [Related]
15. Platelets promote the adhesion of human hepatoma cells with a highly metastatic potential to extracellular matrix protein: involvement of platelet P-selectin and GP IIb-IIIa.
Yu Y; Zhou XD; Liu YK; Ren N; Chen J; Zhao Y
J Cancer Res Clin Oncol; 2002 May; 128(5):283-7. PubMed ID: 12029445
[TBL] [Abstract][Full Text] [Related]
16. Study on anti-metastasis of heparin derivatives as ligand antagonist of p-selectin.
Li Y; Luo JY; Cui HF; Zheng L; Du SS
Biomed Pharmacother; 2010 Dec; 64(10):654-8. PubMed ID: 20970300
[TBL] [Abstract][Full Text] [Related]
17. Distinct selectin ligands on colon carcinoma mucins can mediate pathological interactions among platelets, leukocytes, and endothelium.
Kim YJ; Borsig L; Han HL; Varki NM; Varki A
Am J Pathol; 1999 Aug; 155(2):461-72. PubMed ID: 10433939
[TBL] [Abstract][Full Text] [Related]
18. The attenuation of experimental lung metastasis by a bile acid acylated-heparin derivative.
Park K; Ki Lee S; Hyun Son D; Ah Park S; Kim K; Won Chang H; Jeong EJ; Park RW; Kim IS; Chan Kwon I; Byun Y; Kim SY
Biomaterials; 2007 Jun; 28(16):2667-76. PubMed ID: 17335894
[TBL] [Abstract][Full Text] [Related]
19. Kinetic analysis of heparin and glucan sulfates binding to P-selectin and its impact on the general understanding of selectin inhibition.
Simonis D; Fritzsche J; Alban S; Bendas G
Biochemistry; 2007 May; 46(20):6156-64. PubMed ID: 17458940
[TBL] [Abstract][Full Text] [Related]
20. Selectin-mucin interactions as a probable molecular explanation for the association of Trousseau syndrome with mucinous adenocarcinomas.
Wahrenbrock M; Borsig L; Le D; Varki N; Varki A
J Clin Invest; 2003 Sep; 112(6):853-62. PubMed ID: 12975470
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
